Skip to main content
SLAS2024 Main banner
Sartorius Ad
Back

Douglas S. Auld, PhD (he/him/his)

Novartis-CBT-HTB-2, Massachusetts, United States

Doug has over 20 years of experience in the drug discovery. He completed his Ph.D. at UNC with Prof. Gary J. Pielak in the Dept. of Chemistry in 1993 and did his post-doctoral training at MIT with Prof. Paul Schimmel (1994-1996). Following post-doctoral training, Doug joined Pharmacopeia at an early stage and helped to build this company. In 2004, Doug was hired by Francis Collins to help start the NIH Chemical Genomics Center (NCGC). At the NCGC he worked to establish a center of scientific excellence which has now become part of the National Center for Advancing Translational Sciences benefiting the improvement of human health. Doug joined Novartis BioMedical Research (NBR) in 2010. At NBR, Doug’s lab provides assay development expertise to support hit discovery and lead optimization efforts. Doug also manages a lab at NBR that provides resources and expertise to support external collaborations.

Disclosure information not submitted.

Presentation(s):